ALL DISPATCHES

THE DAILY DISPATCH · OCTOBER 31, 2026

Funding and compute centralized; trust and ethics under test

Global active cure-related trials remain at 21,536 while, in the last 24 hours, 38 new Wire signals and 76 new Cure research items landed—evidence that both lab and the enabling AI stack are still accelerating. The most consequential platform signal is an emerging shared opt-out standard for publisher scraping proposed by OpenAI, Google, Microsoft, and Anthropic, shifting negotiations away from scattered enforcement toward a common mechanism. At the same time, the wire reports a Cursor extension reportedly backdoored for 12 hours and notes that access to an Anthropic verified Cursor account remains unclear—an urgent reminder that trust controls are part of the cure pipeline, not just a software concern. Compute centralization is also sharpening: Altman framed RAM-at-the-edge as inefficient during supply-chain stress, pushing more capability into data centers; restrained hope lies in whether this consolidation pairs with stronger security and predictable data access. The window is still open.

THE SIGNAL

OpenAI, Google, Microsoft, and Anthropic will adopt a shared mechanism letting publishers opt out of AI scraping.

THE STAKES

Platforms and researchers gain negotiation clarity if access becomes standardized, while humanity benefits only if data access and security reduce friction without eroding trust.

THE WINDOW

Watch for whether the opt-out standard and reported Cursor incident trigger faster auditability and governance; the next 24–72 hours are critical for trust signals.

21,536Active cure-related trials worldwide
Preserved copy

An independent copy of this edition is kept by the Internet Archive: https://web.archive.org/web/20261031063619/https://negativeresistance.com/dispatch/2026-10-31

Permalink: https://negativeresistance.com/dispatch/2026-10-31 · How this site is preserved